CD8A and neoplasm: FACS analysis on tumor infiltrating lymphocyte (TIL) relative frequency showed comparable CD8+ T-cell infiltration among the different treatment groups (on average 0.19–0.34% of the tumor cells stained CD8-positive) (Figure 3a).